Neuroanesthesia & neurocritical care

Visualization of Cerebral Pressure Autoregulatory Insults in Traumatic Brain Injury*

Crit Care MedPublished Observational cohort study

Authors' conclusion

Higher intensities for longer durations of positive PRx and negative ∆CPPopt correlated with worse outcome. Elevated ICP, low CPP, and negative ∆CPPopt were particularly associated with worse outcomes when the cerebral pressure autoregulation was concurrently impaired.

Study context

Population
TBI patients with intracranial pressure (ICP) and arterial BP monitoring and 6-month GOS outcome data, neurocritical care unit, Cambridge, UK
Participants
553 patients
Outcome
Combined effect of insult intensity and duration of PRx and ∆CPPopt (actual CPP − optimal CPP) on outcome (GOS)
Follow-up
6 months
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

Insult intensity and duration of PRx and ∆CPPopt vs GOS (heatmaps)
  • Transition from favorable to unfavorable outcome when PRx remained positive for 30 minutes, and for shorter durations at higher intensity
  • Gradual transition from favorable to unfavorable outcome when ∆CPPopt went below −5 mm Hg for 30-minute episodes, and for shorter durations for more negative ∆CPPopt

Observational data: associations, not effects.

Further findings

Combined PRx/ICP heatmap (% monitoring time)

ICP above 20 mm Hg together with PRx above 0 correlated with unfavorable outcome

Combined PRx/CPP heatmap (% monitoring time)

CPP below 70 mm Hg together with PRx above 0.2-0.4 correlated with unfavorable outcome

Combined PRx/∆CPPopt heatmap (% monitoring time)

∆CPPopt below 0 together with PRx above 0.2-0.4 correlated with unfavorable outcome

Original publication

Visualization of Cerebral Pressure Autoregulatory Insults in Traumatic Brain Injury*. Crit Care Med. Published 8 April 2024. doi:10.1097/ccm.0000000000006287

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.